Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 5, 2020
Previous Article Next Article

Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin

Author affiliations

Abstract

Modified carbocyclic nucleosides (4a–g) constituting 7-deazapurine, 4′-methyl, exocyclic double bond and 2′,3′-hydroxy were synthesized. NOE and X-ray studies of 4c confirmed the α-configuration of 4′-methyl. The anti-HBV assay demonstrated 4e (IC50 = 3.4 μM) without notable cytotoxicity (CC50 = 87.5 μM) as a promising lead for future exploration.

Graphical abstract: Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin

Back to tab navigation

Supplementary files

Article information


Submitted
22 Feb 2020
Accepted
22 Apr 2020
First published
15 May 2020

RSC Med. Chem., 2020,11, 597-601
Article type
Research Article

Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin

R. Samunuri, M. Toyama, R. S. Pallaka, S. Neeladri, A. K. Jha, M. Baba and C. Bal, RSC Med. Chem., 2020, 11, 597
DOI: 10.1039/D0MD00059K

Social activity

Search articles by author

Spotlight

Advertisements